Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2015

Open Access 01-12-2015 | Research

Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population

Authors: Myriam Blanchin, Sarah Dauchy, Alejandra Cano, Anne Brédart, Neil K. Aaronson, Jean-Benoit Hardouin

Published in: Health and Quality of Life Outcomes | Issue 1/2015

Login to get access

Abstract

Background

The Impact of Cancer version 2 (IOCv2) was designed to assess the physical and psychosocial health experience of cancer survivors through its positive and negative impacts. Although the IOCv2 is available in English and Dutch, it has not yet been validated for use in French-speaking populations. The current study was undertaken to provide a comprehensive assessment of the reliability and validity of the French language version of the IOCv2 in a sample of breast cancer survivors.

Methods

An adapted French version of the IOCv2 as well as demographic and medical information were completed by 243 women to validate the factor structure divergent/divergent validities and reliability. Concurrent validity was assessed by correlating the IOCv2 scales with measures from the SF-12, PostTraumatic Growth Inventory and Fear of Cancer Recurrence Inventory.

Results

The French version of the IOCv2 supports the structure of the original version, with four positive impact dimensions and four negative impact dimensions. This result was suggested by the good fit of the confirmatory factor analysis and the adequate reliability revealed by Cronbach's alpha coefficients and other psychometric indices. The concurrent validity analysis revealed patterns of association between IOCv2 scale scores and other measures.
Unlike the original version, a structure with a Positive Impact domain consisting in the IOCv2 positive dimensions and a Negative Impact domain consisting in the negative ones has not been clearly evidenced in this study. The limited practical use of the conditional dimensions Employment Concerns and Relationship Concerns, whether the patient is partnered or not, did not make possible to provide evidence of validity and reliability of these dimensions as the subsets of sample to work with were not large enough. The scores of these conditional dimensions have to be used with full knowledge of the facts of this limitation of the study.

Conclusions

Integrating IOCv2 into studies will contribute to evaluate the psychosocial health experience of the growing population of cancer survivors, enabling better understanding of the multi-dimensional impact of cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Knobf MT. Psychosocial Responses in Breast Cancer Survivors. Semin Oncol Nur. 2007;23(1):71–83.CrossRef Knobf MT. Psychosocial Responses in Breast Cancer Survivors. Semin Oncol Nur. 2007;23(1):71–83.CrossRef
2.
go back to reference Knobf MT. Clinical Update: Psychosocial Responses in Breast Cancer Survivors. Semin Oncol Nurs. 2011;27(3):e1–e14.PubMedCrossRef Knobf MT. Clinical Update: Psychosocial Responses in Breast Cancer Survivors. Semin Oncol Nurs. 2011;27(3):e1–e14.PubMedCrossRef
3.
go back to reference Denlinger CS, Barsevick AM. The Challenges of Colorectal Cancer Survivorship. J Natl Compr Cancer Netw. 2009;7(8):883–94. Denlinger CS, Barsevick AM. The Challenges of Colorectal Cancer Survivorship. J Natl Compr Cancer Netw. 2009;7(8):883–94.
4.
go back to reference Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011;50(2):187–93.PubMedCrossRef Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011;50(2):187–93.PubMedCrossRef
5.
go back to reference Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res. 2008;27:32.PubMedCentralPubMedCrossRef Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res. 2008;27:32.PubMedCentralPubMedCrossRef
6.
go back to reference Rowland KB, Rodriguez JL, Patterson JR, Trivers KF. A literature review of the social and psychological needs of ovarian cancer survivors. Psycho-Oncology. 2013;22(11):2408–18.CrossRef Rowland KB, Rodriguez JL, Patterson JR, Trivers KF. A literature review of the social and psychological needs of ovarian cancer survivors. Psycho-Oncology. 2013;22(11):2408–18.CrossRef
7.
go back to reference Jim HS, Jacobsen PB. Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J. 2008;14(6):414–9.PubMedCrossRef Jim HS, Jacobsen PB. Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J. 2008;14(6):414–9.PubMedCrossRef
8.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. J Natl Cancer Inst. 1993;85(5):365–76.PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. J Natl Cancer Inst. 1993;85(5):365–76.PubMedCrossRef
9.
go back to reference Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure. J Clin Oncol. 1993;11(3):570–9.PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure. J Clin Oncol. 1993;11(3):570–9.PubMed
10.
go back to reference Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res. 2005;14(4):1007–23.PubMedCrossRef Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res. 2005;14(4):1007–23.PubMedCrossRef
11.
go back to reference Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–31.PubMedCrossRef Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–31.PubMedCrossRef
12.
go back to reference Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Oncology. 2006;15(5):407–21.PubMedCentralPubMedCrossRef Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Oncology. 2006;15(5):407–21.PubMedCentralPubMedCrossRef
13.
go back to reference Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B. Refinement and Psychometric Evaluation of the Impact of Cancer Scale. J Natl Cancer Inst. 2008;100(21):1530–41.PubMedCentralPubMedCrossRef Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B. Refinement and Psychometric Evaluation of the Impact of Cancer Scale. J Natl Cancer Inst. 2008;100(21):1530–41.PubMedCentralPubMedCrossRef
14.
15.
go back to reference Dewolf L, Koller M, Velikova G, Johnson C, Scott N, Bottomley A. EORTC Quality of Life Group Translation Procedure. 3rd ed. Brussels: EORTC Quality of Life Group; 2009. Dewolf L, Koller M, Velikova G, Johnson C, Scott N, Bottomley A. EORTC Quality of Life Group Translation Procedure. 3rd ed. Brussels: EORTC Quality of Life Group; 2009.
16.
go back to reference Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Med Care. 1996;34(3):220–33.PubMedCrossRef Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Med Care. 1996;34(3):220–33.PubMedCrossRef
17.
go back to reference Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries: Results from the IQOLA Project. J Clin Epidemiol. 1998;51(11):1171–8.PubMedCrossRef Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries: Results from the IQOLA Project. J Clin Epidemiol. 1998;51(11):1171–8.PubMedCrossRef
18.
go back to reference Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–71.PubMedCrossRef Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–71.PubMedCrossRef
19.
go back to reference Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.PubMedCrossRef Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.PubMedCrossRef
20.
go back to reference Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Test of significance and descriptive goodness-of-fit measures. Methods Psychol Res- Online. 2003;8(2):23–74. Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Test of significance and descriptive goodness-of-fit measures. Methods Psychol Res- Online. 2003;8(2):23–74.
21.
go back to reference Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334.CrossRef Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334.CrossRef
24.
go back to reference Sijtsma K, Molenaar IW. Introduction to Nonparametric Item Response Theory. Thousand Oaks, CA: Sage; 2002. Sijtsma K, Molenaar IW. Introduction to Nonparametric Item Response Theory. Thousand Oaks, CA: Sage; 2002.
25.
go back to reference Oerlemans S, Smith SK, Crespi CM, Zimmerman S, van de Poll-Franse LV, Ganz PA. Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psycho-Oncology. 2013;22(6):1258–65.PubMedCentralPubMedCrossRef Oerlemans S, Smith SK, Crespi CM, Zimmerman S, van de Poll-Franse LV, Ganz PA. Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psycho-Oncology. 2013;22(6):1258–65.PubMedCentralPubMedCrossRef
26.
go back to reference Crespi CM, Smith SK, Petersen L, Zimmerman S, Ganz PA. Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors. J Cancer Surviv. 2010;4(1):45–58.PubMedCentralPubMedCrossRef Crespi CM, Smith SK, Petersen L, Zimmerman S, Ganz PA. Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors. J Cancer Surviv. 2010;4(1):45–58.PubMedCentralPubMedCrossRef
27.
go back to reference Smith SK, Crespi CM, Petersen L, Zimmerman S, Ganz PA. The Impact of Cancer and Quality of Life for Post-Treatment Non-Hodgkin Lymphoma Survivors. Psycho-Oncology. 2010;19(12):1259–67.PubMedCentralPubMedCrossRef Smith SK, Crespi CM, Petersen L, Zimmerman S, Ganz PA. The Impact of Cancer and Quality of Life for Post-Treatment Non-Hodgkin Lymphoma Survivors. Psycho-Oncology. 2010;19(12):1259–67.PubMedCentralPubMedCrossRef
28.
go back to reference Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK. Quality of Life in Patients Treated for Penile Cancer. J Urol. 2014;192(4):1105–10.PubMedCrossRef Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK. Quality of Life in Patients Treated for Penile Cancer. J Urol. 2014;192(4):1105–10.PubMedCrossRef
Metadata
Title
Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population
Authors
Myriam Blanchin
Sarah Dauchy
Alejandra Cano
Anne Brédart
Neil K. Aaronson
Jean-Benoit Hardouin
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2015
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-015-0301-x

Other articles of this Issue 1/2015

Health and Quality of Life Outcomes 1/2015 Go to the issue